 |
|
Vaginal Ultrasonography to Evaluate Postmenopausal Bleeding
Karen J. Carlson, MD
JAMA. 1998;280:1529-1530.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Even before the era of hormone replacement therapy, postmenopausal vaginal bleeding was a common problem. But now, increasing use of hormone replacement therapy (HRT) has made abnormal bleeding an even more frequent reason for office visits. Current guidelines from the American College of Obstetricians and Gynecologists recommend endometrial biopsy for women who are taking continuous combined HRT and have bleeding for more than 6 months after starting treatment, and for any prolonged or irregular bleeding in women taking cyclic HRT. About 20% of postmenopausal women taking continuous combined HRT still have bleeding at 12 months; variations in bleeding patterns in women taking cyclic HRT are common.1 Thus, a substantial number of postmenopausal women will face the prospect of diagnostic testing to evaluate abnormal vaginal bleeding.
In the 1980s, office endometrial biopsy supplanted dilatation and curettage as the initial procedure for evaluation of postmenopausal bleeding. However, endometrial . . . [Full Text of this Article]
From the Medical Service and Vincent Obstetrics and Gynecology Service, Massachusetts General Hospital, and Harvard Medical School, Boston, Mass.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Endovaginal Ultrasound to Exclude Endometrial Cancer and Other Endometrial Abnormalities
Rebecca Smith-Bindman, Karla Kerlikowske, Vickie A. Feldstein, Leslee Subak, Juergen Scheidler, Mark Segal, Richard Brand, and Deborah Grady
JAMA. 1998;280(17):1510-1517.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Endovaginal Ultrasound to Evaluate Vaginal Bleeding in Postmenopausal Women
JWatch General 1998;1998:5-5.
FULL TEXT
|
